TY - JOUR
T1 - Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli
AU - Naveed, Ahsan
AU - Yu, Jieshi
AU - Lawson, Steven
AU - Gao, Rongyuan
AU - Ni, Shuisong
AU - Paulchakrabarti, Mousumi
AU - Choudhury, Biswa
AU - Christopher-Hennings, Jane
AU - Nelson, Eric
AU - Sheng, Zizhang
AU - Kennedy, Michael A.
AU - Li, Feng
AU - Wang, Dan
N1 - Publisher Copyright:
© 2024
PY - 2024/9
Y1 - 2024/9
N2 - The hemagglutinin-esterase-fusion (HEF) protein binds 9-O-acetylated sialic acids-containing glycans on the cell surface and drives influenza D virus (IDV) entry. The HEF is a primary determinant of the exceptional thermal and acid stability observed in IDV infection biology. Here, we expressed and purified the receptor binding domain (RBD) of the IDV HEF protein in Escherichia coli and characterized its receptor binding and antigenic properties. The data from these experiments indicate that (i) the RBD can bind with specificity to turkey red blood cells (RBC), and its binding can be specifically inhibited by IDV antibody; (ii) the RBD efficiently binds to the cell surface of MDCK cells expressing the receptor of IDV; and (iii) anti-RBD antibodies are capable of blocking RBD attachment to MDCK cells as well as of inhibiting the virus from agglutinating RBCs. These observations support the utility of this RBD in future receptor and entry studies of IDV.
AB - The hemagglutinin-esterase-fusion (HEF) protein binds 9-O-acetylated sialic acids-containing glycans on the cell surface and drives influenza D virus (IDV) entry. The HEF is a primary determinant of the exceptional thermal and acid stability observed in IDV infection biology. Here, we expressed and purified the receptor binding domain (RBD) of the IDV HEF protein in Escherichia coli and characterized its receptor binding and antigenic properties. The data from these experiments indicate that (i) the RBD can bind with specificity to turkey red blood cells (RBC), and its binding can be specifically inhibited by IDV antibody; (ii) the RBD efficiently binds to the cell surface of MDCK cells expressing the receptor of IDV; and (iii) anti-RBD antibodies are capable of blocking RBD attachment to MDCK cells as well as of inhibiting the virus from agglutinating RBCs. These observations support the utility of this RBD in future receptor and entry studies of IDV.
KW - Bovine influenza
KW - Hemagglutinin-esterase-fusion protein
KW - Receptor binding domain
KW - Type D
UR - http://www.scopus.com/inward/record.url?scp=85195879158&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85195879158&partnerID=8YFLogxK
U2 - 10.1016/j.virol.2024.110138
DO - 10.1016/j.virol.2024.110138
M3 - Article
C2 - 38880069
AN - SCOPUS:85195879158
SN - 0042-6822
VL - 597
JO - Virology
JF - Virology
M1 - 110138
ER -